Regulation of matrix metalloproteinases 2 and 9 in corneal neovascularization-Reference-Cited by-全球学者库

Regulation of matrix metalloproteinases 2 and 9 in corneal neovascularization

Published:2020-02-16 Issue:5 Volume:95 Page:485-492
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Zhang Jiahao¹,Wang Shurong¹,He Yuxi¹,Yao Boyuan¹,Zhang Yan¹^ORCID

Affiliation:

1. Department of Ophthalmology 2nd Hospital of Jilin University Changchun China

Funder

Department of Science and Technology of Jilin Province

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cbdd.13529

Reference71 articles.

1. Membrane type‐1 matrix metalloproteinase (MT1‐MMP) correlates with the expression and activation of matrix metalloproteinase‐2 (MMP‐2) in inflammatory breast cancer;Al‐Raawi D.;International Journal of Clinical and Experimental Medicine,2011

2. Metalloproteinase inhibitors: biological actions and therapeutic opportunities

3. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

4. Insights into MMP-TIMP Interactions

5. The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macromolecular carrier with long retention and body-temperature triggered nitric oxide release for corneal alkali burn therapy via leptin-related signaling;Nano Today;2024-02

2. Electrical stimulation promoting the angiogenesis in diabetic rat perforator flap through attenuating oxidative stress-mediated inflammation and apoptosis;PeerJ;2024-01-31

3. Activatable Probes for Ratiometric Imaging of Endogenous Biomarkers In Vivo;ACS Nano;2024-01-23

4. Development of Osthole-Loaded Microemulsions as a Prospective Ocular Delivery System for the Treatment of Corneal Neovascularization: In Vitro and In Vivo Assessments;Pharmaceuticals;2023-09-22

5. Lipoxin A4 (LXA4) Reduces Alkali-Induced Corneal Inflammation and Neovascularization and Upregulates a Repair Transcriptome;Biomolecules;2023-05-13